JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heard, G. S.
Right arrow Articles by Prins, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heard, G. S.
Right arrow Articles by Prins, D. D.

Journal of the American Podiatric Medical Association, Vol 87, Issue 4 153-164, Copyright © 1997 by American Podiatric Medical Association


JOURNAL ARTICLE

PMMA bead versus parenteral treatment of Staphylococcus aureus osteomyelitis

GS Heard, LM Oloff, DA Wolfe, MD Little and DD Prins
Podiatry Section, Stanford University, Palo Alto, CA, USA.

A. rabbit model of Staphylococcus aureus osteomyelitis was used to compare 3 weeks of clindamycin-impregnated polymethylmethacralate (PMMA) bead treatment with 3 weeks of gentamicin-impregnated polymethylmethacralate bead treatment, 4 weeks of parenteral clindamycin treatment, and surgical debridement without any antibiotic treatment. The animals were weighed throughout the course of the experiment and cortical bone and marrow flush specimens were obtained for bacterial culture at the end of therapy. The cortical specimens were bacteria free in 100% (6/6) of the animals receiving parenteral clindamycin, 83% (5/6) of the animals in the clindamycin PMMA group and, none of the animals in the gentamicin PMMA group. The marrow flush specimens were bacteria free in 83% (5/6) of the animals in the parenteral clindamycin group, 67% (4/6) of the animals in the clindamycin PMMA group, and 40% (2/5) of the animals in the gentamicin PMMA group. While these findings are preliminary and further studies with larger numbers of animals are needed, the authors suggest that when PMMA bead therapy is being contemplated, serious consideration should be given to replacing gentamicin with clindamycin in treatment of gram-positive osteomyelitis. Furthermore, incorporation of clindamycin with gentamicin (or tobramycin) should be considered when treating mixed gram-positive and gram-negative osteomyelitis.


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
K. L. Tyrrell, D. M. Citron, J. R. Jenkins, and E. J. C. Goldstein
Periodontal Bacteria in Rabbit Mandibular and Maxillary Abscesses
J. Clin. Microbiol., March 1, 2002; 40(3): 1044 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Podiatr. Med. Assoc.Home page
C. Funk and G. Young
Subtotal Pedal Amputations: Biomechanical and Intraoperative Considerations
J Am Podiatr Med Assoc, January 1, 2001; 91(1): 6 - 12.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Podiatric Medical Association.